- GLP-1 Benefits, Risks Detailed in ‘Atlas’ Mapping Outcomes Medscape
- Mapping the effectiveness and risks of GLP-1 receptor agonists Nature.com
- Scientists warn against new risks of Ozempic and other popular weight loss drugs The Times of India
- Ozempic’s health benefits keep growing, but are the risks worth it? Fox News
- GLP-1 Medications: A dual impact on health benefits and side effects The Economic Times
GLP-1 Benefits, Risks Detailed in ‘Atlas’ Mapping Outcomes MedscapeMapping the effectiveness and risks of GLP-1 receptor agonists Nature.comScientists warn against new risks of Ozempic and other popular weight loss drugs The Times of IndiaOzempic’s health benefits keep growing, but are the risks worth it? Fox NewsGLP-1 Medications: A dual impact on health benefits and side effects The Economic Times Top stories – Google News
